WhiteSwell Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Liquidation
- (Announced)
- Investors
-
8
WhiteSwell General Information
Description
Operator of a science-driven company intended to improve the treatment of acute decompensated heart failure by leveraging the lymphatic system. The company provides a medical device to create a low-pressure zone at the thoracic duct outlet to reduce resistance to lymphatic drainage and improve clinical outcomes for ADHF patients, enabling the healthcare industry to address the unmet need for effective and safe treatment options for ADHF, a serious condition with high mortality rates.
Contact Information
Website
www.whiteswell.comCorporate Office
- Parkmore Business Park West
- Parkmore
- Galway H91 PTT8
- Ireland
Corporate Office
- Parkmore Business Park West
- Parkmore
- Galway H91 PTT8
- Ireland
WhiteSwell Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Bankruptcy: Liquidation | 27-Jul-2026 | Announced | Clinical Trials - Phase 2 | |||
| 5. Later Stage VC | 25-Feb-2025 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC | 16-Oct-2023 | Completed | Clinical Trials - Phase 2 | |||
| 3. Later Stage VC | 24-Jun-2022 | Completed | Clinical Trials - Phase 2 | |||
| 2. Early Stage VC (Series B) | 11-Dec-2018 | $30M | $30M | Completed | Clinical Trials - Phase 2 | |
| 1. Early Stage VC | Completed | Startup |
WhiteSwell Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B Convertible Preferred | ||||||||
| Series B Convertible Preferred | ||||||||
| Series A-3 Convertible Preferred | ||||||||
| Series A-2 Convertible Preferred | ||||||||
| Series A-1 Convertible Preferred | ||||||||
| Ordinary | 93,721 | $0.010000 | $40 | $40 | 1x | $40 | 5.18% | |
| Series B | 250,207 | $0.010000 | $40 | $40 | 1x | $40 | 13.82% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
WhiteSwell Comparisons
Industry
Financing
Details
WhiteSwell Competitors (3)
One of WhiteSwell’s 3 competitors is Procyrion, a Venture Capital-Backed company based in Houston, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Procyrion | Venture Capital-Backed | Houston, TX | ||||
| Reprieve Cardiovascular | Venture Capital-Backed | Milford, MA | ||||
| Revamp Medical | Venture Capital-Backed | Netania, Israel |
WhiteSwell Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
WhiteSwell Patents
WhiteSwell Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4780528-A1 | Reinforced flexible catheter and methods for use and manufacture | Pending | 22-Sep-2023 | ||
| WO-2025062183-A1 | Reinforced flexible catheter and methods for use and manufacture | Inactive | 22-Sep-2023 | ||
| EP-4694963-A1 | Catheter bearing arrangement | Pending | 14-Apr-2023 | ||
| US-20240350794-A1 | Catheter bearing arrangement | Pending | 14-Apr-2023 | ||
| WO-2024213933-A1 | Catheter bearing arrangement | Inactive | 14-Apr-2023 | F04D29/056 |
WhiteSwell Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
WhiteSwell Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| VI Ventures | Venture Capital | Minority | ||
| Abiomed | Corporation | Minority | ||
| Blackwell Partners | Asset Manager | Minority | ||
| Enterprise Ireland | Growth/Expansion | Minority | ||
| IBI Investment House | Corporation | Minority |
WhiteSwell FAQs
-
When was WhiteSwell founded?
WhiteSwell was founded in 2014.
-
Where is WhiteSwell headquartered?
WhiteSwell is headquartered in Galway, Ireland.
-
What is the size of WhiteSwell?
WhiteSwell has 23 total employees.
-
What industry is WhiteSwell in?
WhiteSwell’s primary industry is Therapeutic Devices.
-
Is WhiteSwell a private or public company?
WhiteSwell is a Private company.
-
What is WhiteSwell’s current revenue?
The current revenue for WhiteSwell is .
-
How much funding has WhiteSwell raised over time?
WhiteSwell has raised $30M.
-
Who are WhiteSwell’s investors?
VI Ventures, Abiomed, Blackwell Partners, Enterprise Ireland, and IBI Investment House are 5 of 8 investors who have invested in WhiteSwell.
-
Who are WhiteSwell’s competitors?
Procyrion, Reprieve Cardiovascular, and Revamp Medical are competitors of WhiteSwell.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
